Skip to main content

Table 2 Genes differentially expressed between metaplastic breast cancer and invasive ductal triple negative breast cancer samples

From: Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes

Gene

Log2 Fold Change

p-value

FDR-adjusted p-value

Genes upregulated in metaplastic samples

 PTHLH

4.11

1.90E-05

4.43E-04

 IGFBP3

1.97

6.59E-05

1.23E-03

 ICAM1

1.71

6.57E-04

8.83E-03

 IER3

1.72

8.62E-04

1.07E-02

 BST2

1.56

1.23E-03

1.43E-02

 HAS2

1.93

2.48E-03

2.45E-02

 PDPN

1.95

2.47E-03

2.45E-02

 IL6

2.31

2.64E-03

2.54E-02

 COL5A1

1.52

3.86E-03

3.12E-02

 FN1

1.53

3.59E-03

3.12E-02

 IL8

2.02

4.87E-03

3.80E-02

 PLAT

1.77

5.52E-03

3.99E-02

 COL5A2

1.52

5.77E-03

4.04E-02

 COL1A1

1.67

5.93E-03

4.07E-02

 INHBA

1.49

6.65E-03

4.47E-02

 CDH11

1.15

7.22E-03

4.53E-02

 MYLK

1.32

7.13E-03

4.53E-02

 CTGF

1.37

7.31E-03

4.53E-02

Genes downregulated in metaplastic samples

 PRR9

−5.10

2.55E-15

8.58E-13

 LCE3E

−31.84

3.33E-14

5.60E-12

 LCE1F

−5.76

1.43E-11

1.60E-09

 FAM25A

−3.87

2.89E-10

2.43E-08

 AGPAT9

−2.65

5.29E-10

3.45E-08

 DUSP8

−2.14

6.17E-10

3.45E-08

 FAM83A-AS1

−3.61

4.15E-08

1.99E-06

 FGFBP2

−0.26

1.20E-07

5.06E-06

 CHAC1

−2.84

3.57E-07

1.33E-05

 HSPE1

− 2.07

1.10E-06

3.69E-05

 CD24

−2.90

1.57E-06

4.80E-05

 ALOXE3

−3.54

4.81E-06

1.35E-04

 ERBB2

−1.24

1.22E-05

3.16E-04

 RIMS3

−1.36

1.98E-05

4.43E-04

 ACTBL2

−3.04

2.11E-05

4.44E-04

 KLK6

−3.51

3.69E-05

7.30E-04

 LCE3D

−4.12

8.55E-05

1.51E-03

 ABCB1

−2.20

1.15E-04

1.94E-03

 LOC100130238

−2.86

2.12E-04

3.39E-03

 BMP6

−2.06

4.06E-04

6.19E-03

 TMCC2

−1.55

5.38E-04

7.86E-03

 LEP

−2.77

6.05E-04

8.47E-03

 ZSCAN12P1

−1.70

8.46E-04

1.07E-02

 CCL26

−1.96

9.29E-04

1.11E-02

 MAL

−2.26

1.38E-03

1.54E-02

 ERBB3

−1.85

2.29E-03

2.41E-02

 NOV

−1.52

2.26E-03

2.41E-02

 PAPL

−1.91

2.88E-03

2.69E-02

 DSCAM

−2.87

3.76E-03

3.12E-02

 KRT81

−2.34

3.69E-03

3.12E-02

 TAGLN3

− 2.02

3.90E-03

3.12E-02

 ZNF165

−1.39

3.44E-03

3.12E-02

 CALML5

−2.55

5.00E-03

3.82E-02

 DIRAS3

−1.69

5.52E-03

3.99E-02

 ARHGAP33

−0.66

5.58E-03

3.99E-02

 RASD2

−1.24

6.92E-03

4.53E-02

 FAM46B

−1.20

7.41E-03

4.53E-02

 PDGFB

−0.79

8.17E-03

4.90E-02

  1. FDR false-discovery rate